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Abstract: Nanotechnology has been described as a general purpose technology. It has already 
generated a range of inventions and innovations. Development of nanotechnology will provide 
clinical medicine with a range of new diagnostic and therapeutic opportunities such as medical 
imaging, medical diagnosis, drug delivery, and cancer detection and management. Nanoparticles 
such as manganese, polystyrene, silica, titanium oxide, gold, silver, carbon, quantum dots, and 
iron oxide have received enormous attention in the creation of new types of analytical tools for 
biotechnology and life sciences. Labeling of stem cells with nanoparticles overcame the prob-
lems in homing and fixing stem cells to their desired site and guiding extension of stem cells 
to specific directions. Although the biologic effects of some nanoparticles have already been 
assessed, information on toxicity and possible mechanisms of various particle types remains 
inadequate. The aim of this review is to give an overview of the mechanisms of internalization 
and distribution of nanoparticles inside stem cells, as well as the influence of different types of 
nanoparticles on stem cell viability, proliferation, differentiation, and cytotoxicity, and to assess 
the role of nanoparticles in tracking the fate of stem cells used in tissue regeneration.
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Nanotechnology
Nanotechnology is defined as the technology that deals with objects of nanometer 
(10-9 meter) size. It refers to the research and development which leads to the 
controlled manipulation and study of structures and devices in the range of 1–100 
nanometers.1,2 It involves imaging, measuring, modeling, and manipulating matter 
at this measurement size.3 In addition, nanotechnology entails the use of atomic, 
molecular, and submolecular structures as core building blocks to create new products 
and devices. The resulting products and devices are collectively called nanomateri-
als. Each element is known as a nanoparticle.4
Nanoparticles can have different shapes and compositions. Their very small size 
imparts physical and chemical properties, particularly their high surface to volume 
ratio, surface tailorability, improved solubility, multifunctionality, high electrical and 
heat conductivity, and improved surface catalytic activity that are very different to 
those of the same material in the bulk form.5 These nanoparticles can be categorized 
into carbon-based materials, such as fullerenes and carbon nanotubes, and inorganic 
nanoparticles including the ones based on metal oxides (eg, zinc oxide, iron oxide, 
titanium dioxide, and cerium oxide), metals (gold, silver, and iron) and quantum dots 
(cadmium sulfide and cadmium selenide).Clinical Pharmacology: Advances and Applications 2010:2 10
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Mixtures of different phases are also manufactured. In 
addition, these nanomaterials also present different and 
interesting morphologies such as spheres, tubes, rods, and 
prisms. Nanotechnology includes the integration of these 
nanoscale structures into larger material components and 
systems, keeping the control and construction of new and 
improved materials at the nanoscale.6
Nanotechnology has been described as a general 
  purpose technology. It has already generated a range of 
  inventions and innovations. The scientific knowledge base 
of nanotechnology is considered to be very interdisciplinary 
and multidisciplinary, combining various subfields of 
  physics and chemistry in its extension of material sciences.3 
  Manufactured nanoparticles are currently used to develop 
products in many fields including communication, 
  engineering, electronics, optics, energy, computer science, 
biology, pharmaceuticals, chemistry, cosmetics, the food 
industry, environmental analysis and remediation, catalysis, 
and material sciences.6–8
Nanomedicine
One of the major developments in nanotechnology and 
  nanoscience studies is the production and application   
of nanoparticles in medical sciences, which is referred as nano-
medicine. It portends a potentially endless range of applications 
from biomedical imaging and drug delivery to therapeutics 
and tissue regeneration, as well as the development of new 
medical products.9
Nanotechnology uses engineered materials or devices 
with the smallest functional organization that are able to 
interact with biologic systems at a molecular level. Thus, they 
may stimulate, respond to, and interact with target cells and 
tissues in order to induce desired physiologic responses while 
minimizing undesirable side effects. Furthermore, nano-
medicine may offer ways to manipulate complex biologic 
systems with greater selectivity and timing than conventional 
pharmacologic approaches.10 The chemistry and physics of 
materials change more notably with size at the sub-100 nm 
length scales. Transcription and translation within a cel-
lular organism occurs within the subnanometer range, and 
with the advent of techniques and technologies available to 
create materials small enough to interact selectively with 
biologic molecules such as nucleic acids and proteins, new 
  opportunities to study cellular level activities are being made 
available.11 Nanometer-sized particles are in the same range of 
dimension as antibodies, membrane receptors, nucleic acids, 
and proteins, among other biomolecules. These biomimetic 
features, together with their high surface to volume ratio 
and the possibility of modulating their properties, make 
  nanoparticles powerful tools for imaging, diagnosis, and 
therapy.7 Nanomedicine includes nanoparticles that act as 
biologic mimetics (eg, functionalized carbon nanotubes), 
“nanomachines” (eg, those made from interchangeable 
DNA parts and DNA scaffolds such as the octahedron and 
stick cube), nanofibers, and polymeric nanoconstructs as 
biomaterials (eg, molecular self-assembly and nanofibers 
of peptides and peptide-amphiphiles for tissue engineering, 
shape-memory polymers as molecular switches, and 
nanoporous membranes), and nanoscale microfabrication-
based devices (eg, silicon microchips for drug release, and 
micromachined hollow needles and two-dimensional needle 
arrays from single crystal silicon), sensors, and laboratory 
diagnostics.12
Development of nanotechnology will provide clinical 
medicine new opportunities in different areas such as medical 
imaging, medical diagnosis, drug delivery, and cancer 
  detection and management.
Medical imaging
Nanoparticles can provide significant improvements in 
traditional biologic imaging of cells and tissues using 
fluorescence microscopy as well as in modern magnetic 
resonance imaging (MRI) of various regions of the body.9 
In optical imaging techniques, nanoparticles have helped to 
overcome the limitations of the organic fluorophores used 
currently which are not photostable and have low intensity. 
For example, quantum dots are resistant to photobleaching 
and photo, chemical, and metabolic degradation. In addition, 
superparamagnetic iron oxide nanoparticles have already 
been proven to be effective in increasing contrast in magnetic 
imaging, serving as a complement to gadolinium-based 
agents, with the ability to resolve the problem of altering the 
relaxation times of selected types of tissue or fluid within 
the body such as the kidney, brain, liver, and bone marrow. 
Superparamagnetic iron oxide nanoparticles have been used 
to detect small metastases in the lymph nodes, enabling 
patients with localized disease to be early treated by surgery 
without being exposed to radiation therapy.13 Iron oxide 
nanocrystals have been used to monitor gene expression 
or detect pathologies such as cancer, brain inflammation, 
arthritis, or atherosclerotic plaques that would not otherwise 
be detectable by conventional MRI.14
Medical diagnosis
The accurate targeting and quantification of molecules 
indicative of cellular disorders at the single-molecule level is Clinical Pharmacology: Advances and Applications 2010:2 11
Nanoparticle-labeled stem cells Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
a demanding task for analysis systems. The combination of 
nanoparticles with other nanotechnology-based materials has 
the potential to address this emerging challenge and provide 
technologies that enable diagnosis at the level of single cells 
and single molecules.7 Antibodies, peptides, proteins, and 
nucleic acids are biologic molecules which could be linked 
covalently to functionalized nanoparticles which have been 
developed as nanoprobes for molecular detection. These func-
tionalized nanoparticles can provide a direct rapid method 
of detection of infectious diseases and viruses in particular 
with high sensitivity.15,16
Drug delivery
Medical therapies have become more tailored to both specific 
diseases and to patients on an individual basis in recent years. 
Most pharmaceutical agents have primary targets within cells 
and tissues; ideally, these agents should be preferentially 
delivered to their sites of action within the cell. Selective 
subcellular delivery is likely to have considerable therapeutic 
benefit.17 The benefits of this type of drug delivery include 
efficient encapsulation of the drug, successful delivery of 
drug to the targeted region of the body, and successful release 
of the drug. Developed nanoscale particles or molecules 
improve the bioavailability of the drug delivery both at 
  specific places in the body and over a longer period of time.18 
Drug delivery systems are based on nanoparticles which have 
a mesoscopic size range of 5–200 nm, allowing their unique 
interaction with biologic systems at the molecular level to 
produce multiple advantages, eg, reduced rate of drug clear-
ance, alteration of the pharmacokinetics and biodistribution 
of the drug, passage of drugs through cell membranes and 
into the cell cytoplasm, and regulated drug release which can 
avoid the tissue damage caused by some drugs.19
There are numerous nanoparticles whose unifying 
feature is the nanometer scale size range. These include 
inorganic nanoparticles (such as metals, metal oxides, and 
metal sulfides), polymeric nanoparticles (such as gelatins, 
chitosan, polylactic acid, and polyglycolic acid), dendrimers, 
liposomes, nanocrystals, and nanotubes.17
Oncology
Nanotechnology is playing an increasingly revolutionary 
role in diagnosis, prognosis, prediction, and management of 
targeted cancer treatment. Development of cancer therapeu-
tic agents has the two-fold aim of achieving greater target 
selectivity and better delivery efficiency. To produce minimal 
damage to normal tissue, therapeutic drugs have been con-
jugated with monoclonal antibodies (mAbs) that selectively 
bind to antigens or receptors which are usually abundantly or 
uniquely expressed on the tumor cell surface. Nanoparticles 
have been shown to overcome both noncellular and cellular-
based drug resistance and to increase selectivity of drugs 
toward cancer cells while reducing their toxicity toward 
normal tissues.20 Several types of anticancer drugs, such as 
liposome-based formulations of several anticancer agents 
(stealth liposomal doxorubicin, liposomal doxorubicin, 
and liposomal daunorubicin) have been approved for the 
  treatment of metastatic breast cancer.21 Nanoparticles can 
deliver the therapeutic agent to the interior of the cancer cell 
after binding to the tumor cell surface, triggering receptor-
mediated endocytosis. Tumor-targeting ligands, such as 
antibodies, growth factors, or cytokines, have been used to 
facilitate the uptake of carriers into target cells.22
Nanomedicine and stem cells
Stem cell therapy is a rapidly evolving area of research in 
regenerative medicine.23,24 Mesenchymal stem cells have 
received considerable attention in the field of cell therapy 
because of their ability to differentiate into various tissues of 
mesenchymal origin (eg, bone, cartilage, fat, muscle, marrow 
stroma, tendon, ligament, and other connective tissues),25 
making them excellent candidates for cell and tissue replace-
ment therapies.26,27 However, there are still some obstacles in 
targeting stem cell therapy, including the problems in homing 
and fixing stem cells to their desired site and guiding exten-
sion of stem cells in specific directions. Nanoparticles have 
been used to overcome these challenges in the therapeutic 
application of stem cells.28
Despite the wide range of applications of nanoparticles 
in the stem cell field, there is a dire lack of information 
  concerning the impact of manufactured nanomaterials on 
human health and the environment.29 This review reviews the 
most recent influences of nanoparticles on stem cell behavior. 
Biocompatibility of nanoparticles is the prerequisite for 
their applications in biomedicine, but this can be misleading 
due to the absence of criteria for evaluating their potential 
toxicity.30
More than 10 million nanoparticles are ingested per 
person every day.31 The nanoparticles are small enough to 
penetrate even very small capillaries throughout the body, 
and can pass through biologic membranes, affecting cell 
function anywhere in the body. This consideration is of 
importance for stem cells, where the effects of nanoparticles 
on the potential for self-renewal and differentiation of stem 
cells is unknown. Data available from toxicity studies of 
nanoparticles, particularly in stem cells, are limited and Clinical Pharmacology: Advances and Applications 2010:2 12
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the molecular mechanisms of nanoparticle toxicity are still 
poorly understood.29
Clinical and experimental studies indicate that a small 
size, a large surface area, and the ability to generate reactive 
oxygen species contributes to the potential of nanoparticles to 
induce cell injury.32 Braydich-Stolle et al29 demonstrated that 
the cytotoxicity of nanoparticles is concentration-dependent. 
  Dramatic changes occurred when cadmium oxide was added to 
germ-line stem cells. Within 48 hours of exposure at cadmium 
oxide concentrations of 1 µg/mL, stem cells were shown to 
shrink and become irregular, with significant inhibition of 
mitochondrial function. At concentrations of cadmium oxide 
higher than 5 µg/mL, stem cells became necrotic and detached 
from the culture dishes.
Development of new techniques to show accurate 
  correlations between in vitro and in vivo studies is imperative 
to portray accurately nanoparticle effects. Moreover, toxicity 
studies are critical to establish the full in vivo potential 
of nanomedicine. Understanding the physicochemical, 
  molecular, and physiologic processes of nanoparticles 
is important for nanomedicine to become a reliable and 
  sustainable treatment modality.33
Cellular uptake of nanoparticles  
by stem cells
Stem cells utilize various endocytic mechanisms for the uptake 
of nanoparticles, including phagocytosis, macropinocytosis, 
clathrin-dependent endocytosis, caveolae-dependent uptake, 
and non-clathrin/non-caveolae endocytosis.34
With regard to silica nanoparticles, mesoporous silica 
conjugated with fluorescein isothiocyanate was efficiently 
internalized into human bone marrow mesenchymal 
stem cells even in short-term incubation.26 The uptake of 
  mesoporous silica nanoparticles was time- and concentration-
dependent. Uptake began as early as 10 minutes after 
  incubation and was relatively rapid within the first 1–2 hours 
of incubation, and a saturation uptake was achieved after 
4 hours of incubation. Chung et al35 demonstrated that inter-
nalization of mesoporous silica nanoparticles was mediated 
by both clathrin- and actin-dependent endocytosis. Huang 
et al30 found that dynamic polymerization of actin fila-
ments has a central role in the uptake of mesoporous silica 
  nanoparticles, and found that inhibition of actin polymer-
ization by cytochalasin D decreased their uptake. Ito et al36 
found that uptake of magnetic iron oxide cationic liposome 
nanoparticles began rapidly, and maximum uptake was 
achieved after 4 hours. The uptake of superparamagnetic 
iron oxide was shown to be mediated via endocytosis in 
human mesenchymal stem cells.25 Numerous studies have 
established a variety of techniques to deliver quantum dots 
into cells, such as microinjection, endocytic compartment, 
electroporation, liposome-mediated transfection, and special 
peptide delivery.37 Chang et al38 investigated cytoskeletal 
reorganization after the uptake of quantum dots which 
revealed the formation of wide and flat leading lamellipodia 
filled with a dense actin network in cells one day after addi-
tion. Liu et al39 studied the endocytic mechanisms of 100 nm 
nanodiamond particles in stem cells and found that these 
particles were taken into the cells by macropinocytosis and 
clathrin-mediated endocytosis. The macropinocytosis was 
mediated by filopodia from cell membrane extension and 
cell-surface ruffling and invagination. It is possible that the 
mechanism of nanoparticle uptake by stem cells is influ-
enced by the type, size, shape, concentration, and surface 
  modification of the nanoparticles.
Location and distribution  
of nanoparticles in stem cells
After internalization of nanoparticles into stem cells, they 
become located in vesicles inside the cytoplasm. For instance, 
polystyrene particles ranging from 40 nm to over 120 nm 
were found scattered in the cell cytoplasm and cytoplasmic 
extension pseudopods.31 The nanoparticles were also located 
in the perinuclear region, forming rings around the cell 
nucleus. Nanodiamond particles of 100 nm were accumulated 
to develop a single nanodiamond cluster in a cytoplasmic 
vesicle, which contained several nanodiamond particles but 
they did not enter the nucleus.39 In addition, after uptake 
into stem cells, superparamagnetic iron oxide nanoparticles 
were located inside the cytoplasm and vesicles, and could 
then be transferred to lysosomes, in which degradation 
of the nanoparticles could occur and free iron be released 
into the cytoplasm.40,41 In the quantum dots studies, Chang 
et al37 found that delivered quantum dots had escaped from 
lysosome degradation at the beginning of the uptake. At 
21 days, lysosome expression was enhanced and almost 
all the cellular quantum dots were observed in lysosome 
vesicles at this time.
Effects on viability, morphology, 
and proliferation of stem cells
The influences of different types of nanoparticles on the 
behavior of stem cells have been evaluated by several 
studies. Huang et al26 and Chung et al35 concluded that 
  internalization of mesoporous silica nanoparticles conjugated 
with fluorescein isothiocyanate in human bone marrow Clinical Pharmacology: Advances and Applications 2010:2 13
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  mesenchymal stem cells did not affect stem cell viability 
and proliferation. They proved that silica nanoparticles could 
escape from endolysosomal vesicles and retained their archi-
tectonic integrity after internalization. In addition, Huang 
et al30 reported that silica nanoparticles can enhance actin 
polymerization induction in mesenchymal stem cells.
Ito et al36 demonstrated that magnetic nanoparticles 
could be used to expand mesenchymal stem cells efficiently 
for clinical application. Mesenchymal stem cells incubated 
in osteogenic medium with magnetite iron oxide cationic 
liposomes changed their shape from fibroblastic to polygonal 
and formed calcium nodules. When mesenchymal stem 
cells were seeded at high density using magnetite cationic 
  liposomes, there was a five-fold increase in the number of 
cells, compared with numbers seen in culture prepared with-
out magnetite cationic liposomes. The survival rate of stem 
cells cultured in a medium containing superparamagnetic iron 
oxide was very high (97%–99%) indicating that superpara-
magnetic iron oxide did not affect stem cell viability.23,25,41,42 
These observations suggest a promising role for nanomedi-
cine in stem cell-related therapies. Selection of type and 
concentration of nanoparticles is critically important.
Kea et al43 showed for the first time, that neural stem cells 
derived from bone marrow stroma of rhesus monkeys could 
be labeled in vitro with the superparamagnetic iron oxide 
contrast agent Feridex and Poly-L-Lysine without affecting 
morphology, cell cycle, telomerase activity, proliferation, 
and differentiation ability of the labeled cells. Huang et al24 
detected that ferucarbotran nanoparticles could promote the 
growth of human mesenchymal stem cells due to their ability 
to diminish intracellular H2O2 through intrinsic peroxidase-
like activity. They reported that ferucarbotran could acceler-
ate cell cycle progression mediated by free iron released from 
lysosomal degradation and involved alteration of iron on the 
expression of protein regulators of the cell cycle. Jung et al44 
studied the topologic and physical properties of the fibrin-
poly(lactide-caprolactone) scaffolds. These nanoparticles 
were designed to improve stem cell seeding efficiency and 
cell in-growth, while enabling maintenance of the mechani-
cal integrity and efficient delivery of mechanical signals to 
adherent cells and lead to a stronger biologic response.
On the other hand, embryonic stem cells cultured in 
low concentration (0.4 million/mL) polystyrene nanopar-
ticles became mostly columnar and embryoid body-
shaped. However, in high concentration (12.2 million/mL) 
  nanoparticles, they became fibroblast-like and less squa-
mous types. At the 24-hour time point, the presence of 
the nanoparticles reduced viability of the embryonic stem 
cells by 40% and 30% in the low versus high relative con-
centration of nanoparticles, respectively. After six days of 
culture, there was a significantly smaller cell surface area 
associated with embryonic stem cells exposed to polystyrene 
nanoparticles compared with controls which was not con-
centration-dependent. This effect indicated the disruption 
of cytoskeletal development. In contrast, the nanoparticles 
did not have an effect on the size of the embryonic stem 
cell nucleus.31
Effect on stem cell differentiation
It is still controversial whether magnetic labeling with 
  superparamagnetic iron oxide inhibits chondrogenic 
  differentiation of mesenchymal stem cells.45 Meanwhile, 
Heymer et al,25 Delcroix et al,23 and Wang et al42 detected 
that superparamagnetic iron oxide did not affect human mes-
enchymal stem cells undergoing adipogenic, osteogenic, or 
myogenic differentiation. In addition, naringin nanoparticles 
in concentrations (1–100 µg/mL) could enhance the prolifera-
tion and osteogenic differentiation of human bone mesenchy-
mal stem cells.46 Au et al47 detected that superparamagnetic 
iron oxide labeling did not affect the calcium-handling 
properties of cardiomyocytes derived from embryonic stem 
cells. Moreover, transplantation of superparamagnetic iron 
oxide labeled embryonic stem cells via direct injection into 
infarcted myocardium resulted in significant improvement in 
heart function. These findings demonstrated the feasibility of 
in vivo tracking of embryonic stem cells using superparamag-
netic iron oxide labeling and cardiac MRI, without affecting 
the cardiac differentiation potential and functional properties 
of embryonic stem cells.
In their study of silica nanoparticles, Huang et al30 
  concluded that the uptake of mesoporous silica nanoparticles 
into human mesenchymal stem cells did not affect regular 
osteogenic differentiation of these cells. In vitro osteogenesis 
was successfully induced in the mesenchymal stem cells 
in highly chondrogenic synovium after the uptake of 
  mesoporous silica nanoparticles.48
Fibrin-polylactide-caprolactone (PLCL) nanoparticles 
facilitated the upregulation of chondrogenesis marker genes 
and chondrogenic differentiation in vitro. The nanopar-
ticle-fibrin-PLCL complex had chemical and physiologic 
  characteristics designed to induce chondrogenic differentia-
tion to sustain their lineage in the complex. In vitro and in vivo 
studies revealed that the complex developed effectively 
sustained chondrogenic differentiation and led to significant 
enhancement of the chondral extracellular matrix deposition 
on human adipogenic stem cells-fibrin-PLCL nanoparticle Clinical Pharmacology: Advances and Applications 2010:2 14
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complex constructs. This complex will be useful for in situ 
cartilage tissue engineering using human stem cells.44
In contrast, Oliveira et al49 showed that direct exposure 
to biphasic calcium phosphate particles impaired human 
mesenchymal stem cell osteogenic differentiation and 
bone matrix mineralization. They added that exposure to 
  calcium-deficient apatite particles severely impaired human 
mesenchymal stem cell osteogenic maturation owing to the 
uptake of Ca2+ from the culture media.
Hussain et al50 demonstrated that the level of cytotoxicity 
of nanoparticle-labeled stem cells depended on the type 
of the nanoparticles. Silver nanoparticles were detected 
to be the most toxic, and this cytotoxicity was mediated 
through oxidative stress. Carbon nanomaterials significantly 
impaired phagocytosis and induced cell death in alveolar 
macrophages.51 Polystrene nanoparticles influenced viability 
and differentiation of embryonic stem cells to a minor 
extent.31
In vivo tracking of  
nanoparticle-labeled stem cells
Delivery of sufficient stem cells to the regions of interest 
with the smallest number of cells to untargeted regions 
is a prerequisite for maximizing the therapeutic benefits 
and minimizing possible unwanted effects of stem cell 
therapy. To monitor distribution, density, proliferation, and 
  transdifferentiation of engrafted stem cells, reliable cellular 
imaging techniques are required.42
Tracking the fate of stem cells employed in devel-
opmental biology and tissue regeneration is essential to 
understand how these cells participate in tissue repair. 
Inorganic probes with special physical properties have 
been developed using different systems of detectors such as 
quantum dots, light-emitting semiconductors, mesoporous 
silica nanoparticles, and superparamagnetic nanoparticle 
iron oxide.38
Huang et al26 concluded that the advantages of 
  biocompatibility, durability, and higher efficiency in 
  internalization of mesoporous silica nanoparticles made 
them a better vector for stem cell tracking than others 
  currently used. Silica coating and polyethylene glycolation 
confers additional stability and biocompatibility to the 
magnetic ferrite nanoparticles. Organic dyes incorporated 
into the silica shell enabled the detection of multifunctional 
nanoparticle fluorescence.
Sykova et al52 tracked the fate of embryonic stem cells 
and bone marrow mesenchymal stem cells labeled with 
iron oxide nanoparticles in rats with cortical or spinal 
cord lesions. Cells were either grafted intracerebrally 
and contralaterally to a cortical photochemical lesion, or 
injected intravenously. During the first post-transplantation 
week, grafted cells migrated to the lesion site in the cortex 
or spinal cord and were visible in the lesion on MR images 
as a hypointense signal, persisting for more than 30 days. 
Their studies demonstrated that MRI of grafted stem cells 
labeled with iron oxide nanoparticles is a useful method 
for evaluating cellular migration toward a lesion site.23,52 
Furthermore, Kea et al43 autografted Feridex-labeled neural 
stem cells derived from bone marrow stroma cells into the 
striatum of the rhesus monkey brain. They found that these 
cells survived, differentiated, and were incorporated into   
the brain, and could be reliably tracked using MRI. 
  Concerning articular cartilage repair, labelling with 
  superparamagnetic nanoparticle iron oxide had great 
  potential to visualise human mesenchymal stem cells and 
track their migration after transplantation for articular 
cartilage repair with MRI following intra-articular 
  injection.25,47 Using MRI, Lee et al53 successfully tracked 
the multifunctional nanoparticle-labeled mesenchymal stem 
cells in the hearts of mice at seven days after induction 
of myocardial infarction. Thus, being able to monitor 
the fate of transplanted stem cells in vivo is crucial for 
  developing successful cell therapies. MRI has afforded 
superb spatial resolution and repeated noninvasive imaging 
of magnetically nanoparticle-labeled stem cells, and appears 
to be the best modality for cell imaging.24,52
Conclusion
Internalization of nanoparticles into stem cells had a 
  significant influence on diverse aspects of cell activities. 
  Viability, proliferation, differentiation, cytotoxicity, and 
in vivo tracking of stem cells labeled with nanoparticles 
have been shown to be type- and concentration-dependent. 
Therefore, more studies are needed to investigate the effects 
of different nanoparticles in directing stem cell behavior and 
should provide valuable information about the impact of 
nanoparticles in diagnostic and therapeutic applications.
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